Cited In for PMID: 9445059

Year	Number of Results
1998	2
1999	7
2000	12
2001	5
2002	4
2003	5
2004	5
2005	4
2006	1
2007	3
2008	1
2009	3
2010	3
2011	5
2012	2
2013	3
2014	1
2015	1
2017	1
2018	2
2024	0

1

Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.

Connor RI, Korber BT, Graham BS, Hahn BH, Ho DD, Walker BD, Neumann AU, Vermund SH, Mestecky J, Jackson S, Fenamore E, Cao Y, Gao F, Kalams S, Kunstman KJ, McDonald D, McWilliams N, Trkola A, Moore JP, Wolinsky SM. Connor RI, et al. J Virol. 1998 Feb;72(2):1552-76. doi: 10.1128/JVI.72.2.1552-1576.1998. J Virol. 1998. PMID: 9445059 Free PMC article. Clinical Trial.

2

Design, display and immunogenicity of HIV1 gp120 fragment immunogens on virus-like particles.

Purwar M, Pokorski JK, Singh P, Bhattacharyya S, Arendt H, DeStefano J, La Branche CC, Montefiori DC, Finn MG, Varadarajan R. Purwar M, et al. Vaccine. 2018 Oct 8;36(42):6345-6353. doi: 10.1016/j.vaccine.2018.07.032. Epub 2018 Sep 14. Vaccine. 2018. PMID: 30220462 Free PMC article.

3

Bacterially expressed HIV-1 gp120 outer-domain fragment immunogens with improved stability and affinity for CD4-binding site neutralizing antibodies.

Rathore U, Purwar M, Vignesh VS, Das R, Kumar AA, Bhattacharyya S, Arendt H, DeStefano J, Wilson A, Parks C, La Branche CC, Montefiori DC, Varadarajan R. Rathore U, et al. J Biol Chem. 2018 Sep 28;293(39):15002-15020. doi: 10.1074/jbc.RA118.005006. Epub 2018 Aug 9. J Biol Chem. 2018. PMID: 30093409 Free PMC article.

4

Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.

Rathore U, Saha P, Kesavardhana S, Kumar AA, Datta R, Devanarayanan S, Das R, Mascola JR, Varadarajan R. Rathore U, et al. J Biol Chem. 2017 Jun 16;292(24):10197-10219. doi: 10.1074/jbc.M117.788919. Epub 2017 Apr 26. J Biol Chem. 2017. PMID: 28446609 Free PMC article.

5

A Plant-Derived Multi-HIV Antigen Induces Broad Immune Responses in Orally Immunized Mice.

Rubio-Infante N, Govea-Alonso DO, Romero-Maldonado A, García-Hernández AL, Ilhuicatzi-Alvarado D, Salazar-González JA, Korban SS, Rosales-Mendoza S, Moreno-Fierros L. Rubio-Infante N, et al. Mol Biotechnol. 2015 Jul;57(7):662-74. doi: 10.1007/s12033-015-9856-3. Mol Biotechnol. 2015. PMID: 25779638

6

Mucosal correlates of protection in HIV-1-exposed sero-negative persons.

Shen R, Smith PD. Shen R, et al. Am J Reprod Immunol. 2014 Aug;72(2):219-27. doi: 10.1111/aji.12202. Epub 2014 Jan 16. Am J Reprod Immunol. 2014. PMID: 24428610 Free PMC article. Review.

7

Towards an effective genital herpes vaccine: past lessons and future prospects.

Halford WP. Halford WP. Future Virol. 2007 Jan 1;2(1):1-6. doi: 10.2217/17460794.2.1.1. Future Virol. 2007. PMID: 23843891 Free PMC article. No abstract available.

8

Sieve analysis in HIV-1 vaccine efficacy trials.

Edlefsen PT, Gilbert PB, Rolland M. Edlefsen PT, et al. Curr Opin HIV AIDS. 2013 Sep;8(5):432-6. doi: 10.1097/COH.0b013e328362db2b. Curr Opin HIV AIDS. 2013. PMID: 23719202 Free PMC article. Review.

9

Synthetic immunotherapy induces HIV virus specific Th1 cytotoxic response and death of an HIV-1 infected human cell line through classic complement activation.

Pleguezuelos O, Stoloff GA, Caparrós-Wanderley W. Pleguezuelos O, et al. Virol J. 2013 Apr 4;10:107. doi: 10.1186/1743-422X-10-107. Virol J. 2013. PMID: 23557359 Free PMC article.

10

Neutralizing antibodies to HIV-1 induced by immunization.

McCoy LE, Weiss RA. McCoy LE, et al. J Exp Med. 2013 Feb 11;210(2):209-23. doi: 10.1084/jem.20121827. J Exp Med. 2013. PMID: 23401570 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

68 results

Results by year